E23. Statistical issues in the validation of biomarkers and surrogate endpoints

Statistical issues in the validation of

Statistical issues in the validation of prognostic, predictive, and surrogate biomarkers

✍ Sargent, D. J.; Mandrekar, S. J. 📂 Article 📅 2013 🏛 SAGE Publications 🌐 English ⚖ 239 KB

Biomarkers and surrogate endpoints in cl

Biomarkers and surrogate endpoints in clinical research – some statistical challenges

✍ M. Buyse 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 83 KB

[Statistics for Biology and Health] The

[Statistics for Biology and Health] The Evaluation of Surrogate Endpoints || The History of Surrogate Endpoint Validation

✍ Burzykowski, Tomasz; Molenberghs, Geert; Buyse, Marc 📂 Article 📅 2005 🏛 Springer New York 🌐 English ⚖ 227 KB

The Identification And Use Of Surrogate Endpoints, I.e., Measures That Can Replace Or Supplement Other Endpoints In Evaluations Of Experimental Treatments Or Other Interventions, Is A General Strategy That Has Stimulated Both Enthusiasm And Scepticism. This Book Offers A Balanced Account On This Con

Biomarkers and surrogate end points—the

Biomarkers and surrogate end points—the challenge of statistical validation

✍ Buyse, Marc; Sargent, Daniel J.; Grothey, Axel; Matheson, Alastair; de Gramont, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 280 KB

[Statistics for Biology and Health] The

[Statistics for Biology and Health] The Evaluation of Surrogate Endpoints || An Alternative Measure for Meta-analytic Surrogate Endpoint Validation

✍ Burzykowski, Tomasz; Molenberghs, Geert; Buyse, Marc 📂 Article 📅 2005 🏛 Springer New York 🌐 English ⚖ 338 KB

The Identification And Use Of Surrogate Endpoints, I.e., Measures That Can Replace Or Supplement Other Endpoints In Evaluations Of Experimental Treatments Or Other Interventions, Is A General Strategy That Has Stimulated Both Enthusiasm And Scepticism. This Book Offers A Balanced Account On This Con

The validity of biomarkers as surrogate

The validity of biomarkers as surrogate endpoints in Alzheimer’s disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES)

✍ C. C. Gispen-De Wied; M. Kritsidima; A. J. A. Elferink 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 107 KB